FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to pyrazolyl-substituted benzenesulfoneamide of the formula (I)  where R1 - phenyl that has a substituent at position that can be substituted as a single radical taken among of halogen atom, (C1-C10)-alkyl, sulfamylic group or the group (a)
 where R1 - phenyl that has a substituent at position that can be substituted as a single radical taken among of halogen atom, (C1-C10)-alkyl, sulfamylic group or the group (a)  ; R2 - hydrogen atom, (C1-C10)-alkyl, (C1-C6)-halogenalkyl, cyano-group, carboxyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-carboxyalkyl, (C1-C10)-cyanoalkyl, (C1-C6)-alkoxycarbonylcyano-(C2-C6)-alkenyl, aminocarbonyl, (C1-C6)-amino- -carbonylalkyl, (C1-C6)-N-alkylaminocarbonyl, N-arylaminocarbonyl, (C3-C7)-cycloalkylaminocarbonyl, (C1-C6)-carboxyalkylaminocarbonyl, (C1-C6)-aralkoxycarbonyl-(C1-C6)-alkylaminocarbonyl, (C1-C6)-hydroxyalkyl (values of other radicals are given in p. 1 of the invention claim). Compounds of the formula (I) are useful for treatment of patients with vascular diseases, migraine, thyroid gland inflammation. EFFECT: enhanced effectiveness of compounds. 19 cl, 12 tbl, 262 ex
; R2 - hydrogen atom, (C1-C10)-alkyl, (C1-C6)-halogenalkyl, cyano-group, carboxyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-carboxyalkyl, (C1-C10)-cyanoalkyl, (C1-C6)-alkoxycarbonylcyano-(C2-C6)-alkenyl, aminocarbonyl, (C1-C6)-amino- -carbonylalkyl, (C1-C6)-N-alkylaminocarbonyl, N-arylaminocarbonyl, (C3-C7)-cycloalkylaminocarbonyl, (C1-C6)-carboxyalkylaminocarbonyl, (C1-C6)-aralkoxycarbonyl-(C1-C6)-alkylaminocarbonyl, (C1-C6)-hydroxyalkyl (values of other radicals are given in p. 1 of the invention claim). Compounds of the formula (I) are useful for treatment of patients with vascular diseases, migraine, thyroid gland inflammation. EFFECT: enhanced effectiveness of compounds. 19 cl, 12 tbl, 262 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 | 
 | RU2169143C2 | 
| METHOD FOR APPLYING CYCLOOXYGENASE-2 INHIBITOR FOR TREATMENT AND PROPHYLAXIS OF NEOPLASIA | 1997 | 
 | RU2239429C2 | 
| 2-CYCLOOXYGENASE INHIBITORS AS ANTIANGIOGENIC AGENTS | 1997 | 
 | RU2268716C2 | 
| METHOD FOR TREATING INFLAMMATION OR INFLAMMATION-INDUCED DISEASE IN DOGS | 1996 | 
 | RU2253456C2 | 
| DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 | 
 | RU2251543C2 | 
| HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 | 
 | RU2173680C2 | 
| SUBSTITUTED ISOXAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INFLAMMATION SUPPRESSION | 1996 | 
 | RU2200158C2 | 
| AMIDINO-DERIVATIVES, THEIR USE AND PHARMACEUTICAL COMPOSITION | 1994 | 
 | RU2136661C1 | 
| SULFONYLALKANOYLAMINO-HYDROXYETHYLAMINO-SULFONAMIDE COMPOUND, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT AND INHIBITION OF RETROVIRAL PROTEASES | 1993 | 
 | RU2146668C1 | 
| AMINOEPOXIDE PREPARATION ACCOMPLISHED AS CONTINUOUS IN SITU SYNTHESIS | 1997 | 
 | RU2194045C2 | 
Authors
Dates
1999-10-10—Published
1994-11-14—Filed